Wilson Sonsini Goodrich & Rosati is pleased to sponsor LaunchBio’s Larger Than Life Science Series: Designed for Success, Early-Phase Study Design for Biotech. At what point in the process should a biotech business think about clinical trial study designs that will carry their idea through FDA approvals? When and how should they retain the services of a CRO to help them along? Join LaunchBio for a conversation with one CRO, Celerion, and one of their clients, Bryn Pharma.